π΅οΈ Darling Ingredients Inc. ($DAR)
SEC insider & ownership activity, last 12 months Β· CIK 916540 Β· every row links its SEC filing
Over the last 12 months insiders sold $6.4M with no open-market buying against it. Randall C. Stuewe sold $3.2M (AugβMar). 1 planned sale is pending, the largest $480K (Gary W. Mize). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 6 sellers, $6.4M (15 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Randall C. Stuewe | 0 | β | 4 | $3.2M | Mar 6, 2026 |
| Van Der Velden Jan | 0 | β | 2 | $1.2M | Feb 18, 2026 |
| John Sterling | 0 | β | 1 | $1.1M | Aug 12, 2025 |
| Dudley Sandra | 0 | β | 3 | $448K | Feb 13, 2026 |
| Kemphaus Nicholas James | 0 | β | 4 | $304K | Feb 13, 2026 |
| Manzi Joseph | 0 | β | 1 | $192K | May 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing β | |
| Dimensional Fund Advisors LP | 5.1% | 13G | Jan 21, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Gary W. Mize | $480K | Jul 9, 2026 | filing β |
| Manzi Joseph | $192K | May 1, 2026 | filing β |
| Randall C. Stuewe | $1.1M | Mar 6, 2026 | filing β |
| Van Der Velden Jan | $1.3M | Feb 17, 2026 | filing β |
| John Sterling | $5.0M | Feb 13, 2026 | filing β |
| Kemphaus Nicholas James | $290K | Feb 13, 2026 | filing β |
| Kemphaus Nicholas James | $178K | Feb 13, 2026 | filing β |
| Dudley Sandra | $615K | Feb 13, 2026 | filing β |
| Randall C. Stuewe | $1.1M | Aug 18, 2025 | filing β |
| John Sterling | $1.0M | Aug 12, 2025 | filing β |
| Randall C. Stuewe | $1.1M | Aug 4, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | May 11, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing β |
| Shareholder vote (5.07) | May 7, 2026 | filing β |
| Earnings (2.02) | Apr 30, 2026 | filing β |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing β |
| Officer/director changes (5.02) | Feb 25, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing β |
| Earnings (2.02) | Feb 11, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing β |
| Earnings (2.02) | Jan 29, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing β |
| Reg FD disclosure (7.01) | Dec 10, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 10, 2025 | filing β |
| Officer/director changes (5.02) | Nov 10, 2025 | filing β |
| Earnings (2.02) | Oct 23, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Oct 23, 2025 | filing β |
| Officer/director changes (5.02) | Sep 26, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Sep 26, 2025 | filing β |
| Officer/director changes (5.02) | Sep 26, 2025 | filing β |